Efficacy of topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in post-refractive surgery chronic dry eye patients with ocular pain
Abstract Background The management of post-refractive surgery dry eye disease (DED) can be challenging in clinical practice, and patients usually show an incomplete response to traditional artificial tears, especially when it is complicated with ocular pain. Therefore, we aim to investigate the effi...
Main Authors: | Lu Zhao, Jiawei Chen, Hongyu Duan, Tingting Yang, Baikai Ma, Yifan Zhou, LinBo Bian, Xiying Cai, Hong Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-024-03294-z |
Similar Items
-
Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen
by: Yuan-Hsi Chan, et al.
Published: (2023-01-01) -
Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease
by: Priyanka V Gandhi, et al.
Published: (2021-01-01) -
Comparison of the clinical effects of two different doses (0.05% and 0.1%) of topical cyclosporine A in dry eyes with meibomian gland dysfunction
by: Kemal Bayrakceken, et al.
Published: (2022-06-01) -
Correction: Efficacy of topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in post-refractive surgery chronic dry eye patients with ocular pain
by: Lu Zhao, et al.
Published: (2024-05-01) -
Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
by: Burade V, et al.
Published: (2020-09-01)